
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization
Yicheng Han, Jiachun Sun, Yanyan Yang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5653-5666
Open Access | Times Cited: 26
Yicheng Han, Jiachun Sun, Yanyan Yang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5653-5666
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities
Yujing Qian, Yujia Yin, Xiaocui Zheng, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Yujing Qian, Yujia Yin, Xiaocui Zheng, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Anti-Tumor Strategies by Harnessing the Phagocytosis of Macrophages
Siyuan Li, Yong-Lin Guo, Jia-Wen Tian, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2717-2717
Open Access | Times Cited: 26
Siyuan Li, Yong-Lin Guo, Jia-Wen Tian, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2717-2717
Open Access | Times Cited: 26
Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability
Tao Wu, Xuan Zhang, Xinxing Liu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Tao Wu, Xuan Zhang, Xinxing Liu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 14
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 14
Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
Wanli Zhang, Luqi Ge, Yiwen Zhang, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Wanli Zhang, Luqi Ge, Yiwen Zhang, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Macrophages as a Potential Immunotherapeutic Target in Solid Cancers
Alok Mishra, Shahid Banday, Ravi Bharadwaj, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 55-55
Open Access | Times Cited: 29
Alok Mishra, Shahid Banday, Ravi Bharadwaj, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 55-55
Open Access | Times Cited: 29
LINC00543 promotes colorectal cancer metastasis by driving EMT and inducing the M2 polarization of tumor associated macrophages
Jinsen Zheng, Rongzhang Dou, Xinyao Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Jinsen Zheng, Rongzhang Dou, Xinyao Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Epigenetics and immunotherapy in colorectal cancer: progress and promise
Tianjiao Dang, Xin Guan, Luying Cui, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Tianjiao Dang, Xin Guan, Luying Cui, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer
Jiali Gong, Danling Cheng, Changcun Liu, et al.
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 5
Jiali Gong, Danling Cheng, Changcun Liu, et al.
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 5
Tumor-associated macrophages as a potential therapeutic target in thyroid cancers
Liya Zhu, Xiu Juan Li, Prakash Gangadaran, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 3895-3917
Open Access | Times Cited: 11
Liya Zhu, Xiu Juan Li, Prakash Gangadaran, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 3895-3917
Open Access | Times Cited: 11
The role of macrophages in liver metastasis: mechanisms and therapeutic prospects
Qin Yuan, Linlin Jia, Jiahua Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Qin Yuan, Linlin Jia, Jiahua Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The role of intestinal macrophage polarization in colitis-associated colon cancer
Yujie Deng, Xuewei Jia, Liu Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yujie Deng, Xuewei Jia, Liu Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Macrophage Membrane-Coated Nanomedicine Enhances Cancer Immunotherapy by Activating Macrophages and T Cells
Yongmei Zhao, Lulu X Pei, Baolin Liu, et al.
Molecular Pharmaceutics (2025)
Closed Access
Yongmei Zhao, Lulu X Pei, Baolin Liu, et al.
Molecular Pharmaceutics (2025)
Closed Access
Harnessing Histone Deacetylase Inhibitors for Enhanced Cancer Immunotherapy
Fatemeh Hedayat, Elnaz Faghfuri
European Journal of Pharmacology (2025) Vol. 997, pp. 177620-177620
Closed Access
Fatemeh Hedayat, Elnaz Faghfuri
European Journal of Pharmacology (2025) Vol. 997, pp. 177620-177620
Closed Access
Unraveling TIMP1: a multifaceted biomarker in colorectal cancer
Xiaode Qiu, Guangqian Quan, Wenquan Ou, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 9
Xiaode Qiu, Guangqian Quan, Wenquan Ou, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 9
Engineered Apoptosis-Bioinspired Nanoparticles Initiate Immune Cascade for Cancer Immunotherapy of Malignant Ascites
Anmin Huang, Feixia Guo, Zhijie Yu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 8, pp. 10371-10382
Closed Access | Times Cited: 7
Anmin Huang, Feixia Guo, Zhijie Yu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 8, pp. 10371-10382
Closed Access | Times Cited: 7
M2 Macrophage Classification of Colorectal Cancer Reveals Intrinsic Connections with Metabolism Reprogramming and Clinical Characteristics
Fengxing Huang, Youwei Wang, Yu Shao, et al.
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 383-399
Open Access | Times Cited: 2
Fengxing Huang, Youwei Wang, Yu Shao, et al.
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 383-399
Open Access | Times Cited: 2
The Potential Use of Exosomes in Anti-Cancer Effect Induced by Polarized Macrophages
Chizumi Abe, Maharshi Bhaswant, Teruo Miyazawa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 1024-1024
Open Access | Times Cited: 6
Chizumi Abe, Maharshi Bhaswant, Teruo Miyazawa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 1024-1024
Open Access | Times Cited: 6
mPPTMP195 nanoparticles enhance fracture recovery through HDAC4 nuclear translocation inhibition
Xinping Chen, Chengwei Li, Jiyu Zhao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Xinping Chen, Chengwei Li, Jiyu Zhao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
A Comprehensive Analysis of LYAR in Colorectal Cancer: Prognostic Marker and Therapeutic Target
Jiaying Wen, Ye‐Ying Fang, Dongming Li, et al.
Cancer Biotherapy and Radiopharmaceuticals (2024) Vol. 39, Iss. 9, pp. 673-689
Closed Access
Jiaying Wen, Ye‐Ying Fang, Dongming Li, et al.
Cancer Biotherapy and Radiopharmaceuticals (2024) Vol. 39, Iss. 9, pp. 673-689
Closed Access
Liposomes Carrying Ergosterol Peroxide and a Repolarization Agent of Tumor-Associated Macrophages for Remodeling the Tumor Microenvironment
Hong Ji, Haijun Dan, Wei Shen, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 18, pp. 22256-22266
Closed Access
Hong Ji, Haijun Dan, Wei Shen, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 18, pp. 22256-22266
Closed Access
Expression of CD68 and CD163 in malignant epithelial cells of oral squamous cell carcinoma: phenotypic shift or mere cell fusion
Ahmed Essa, Mohammed Korayem, Mohammed Alghamdi, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155639-155639
Closed Access
Ahmed Essa, Mohammed Korayem, Mohammed Alghamdi, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155639-155639
Closed Access
Development of a multigram synthetic process to clinical candidate TMP195, a class IIa histone deacetylase selective inhibitor
Siyuan Wang, Wenchao Zhang, Qin Han, et al.
Chemical Papers (2024) Vol. 78, Iss. 18, pp. 9559-9568
Closed Access
Siyuan Wang, Wenchao Zhang, Qin Han, et al.
Chemical Papers (2024) Vol. 78, Iss. 18, pp. 9559-9568
Closed Access
Perspectives on materials: Reality and potential of epigenetic drug nano-delivery
Yunxiang Zhang, Derui Xu, Xianglin Hou, et al.
Chemical Engineering Journal (2024), pp. 157746-157746
Closed Access
Yunxiang Zhang, Derui Xu, Xianglin Hou, et al.
Chemical Engineering Journal (2024), pp. 157746-157746
Closed Access
Super-enhancers reorganization controls re-sensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer
Eros Di Giorgio, Vanessa Tolotto, Nicolò Gualandi, et al.
Research Square (Research Square) (2024)
Open Access
Eros Di Giorgio, Vanessa Tolotto, Nicolò Gualandi, et al.
Research Square (Research Square) (2024)
Open Access